Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer

<p>Abstract</p> <p>Background</p> <p>Within estrogen receptor-positive breast cancer (ER+ BC), the expression levels of proliferation-related genes can define two clinically distinct molecular subtypes. When treated with adjuvant tamoxifen, those ER+ BCs that are lowly...

Full description

Bibliographic Details
Main Authors: Conus Nelly M, Lallemand Francoise, Haibe-Kains Benjamin, Sotiriou Christos, Loi Sherene, Piccart Martine J, Speed Terence P, McArthur Grant A
Format: Article
Language:English
Published: BMC 2009-06-01
Series:BMC Medical Genomics
Online Access:http://www.biomedcentral.com/1755-8794/2/37